FENC vs REGN · rev $44.6M vs P/E 14, rev $14.34B
Fennec Pharmaceuticals Inc (FENC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported FENC revenue for 2025-12-31 was $44.6M. Net income was -$9.7M. Revenue was down 6.1% from 2024-12-31 to 2025-12-31. FENC currently screens at market cap $302.2M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FENC currently screens at market cap $302.2M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FENC and REGN stock pages for the full models.
Not investment advice.